Roche.co.uk

New research finds that Roche handheld diabetes system improves the wellbeing of more than 7 out of 10 respondents

Unique blood sampling device for people with diabetes wins major design award

New research points to benefits of innovative cobas® HPV test for primary screening as England’s cervical cancer screening programme includes the test in current HPV “triage” rollout

Diabetes patients encourage Surrey nurses to join them in October’s Great South Run

Burgess Hill employees join 16,000 colleagues globally to raise money for vulnerable children

TV personality Kate Garraway launches The Personal Touch campaign calling for more of the 1.2 million warfarin users^1,2 to have access to self-monitoring

‘Cervical smear test journey’ tracked through innovative blog to help UK women overcome fear of cervical screens

ATHENA study shows the cobas Human Papillomavirus (HPV) Test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70 percent of cervical cancer

Women in Wales could benefit from a test which makes it easier to pinpoint those most at risk of developing cervical cancer.

An innovative diabetes management concept including structured self-monitoring of blood glucose (SMBG), data visualisation, pattern analysis and derived therapy adjustments can significantly reduce HbA1c values, improve glycaemic control and enhance patients' quality of life. These are the key findings of the 12-month data from the Structured Testing Protocol (STeP) Study, newly published in Diabetes Care and presented at an exclusive event on effective and structured diabetes management held in London on February 18.